Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Heitz

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Cancers|July 26, 2020
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-ImagingHagen Kulbe, Oliver Klein, Zhiyang Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2025
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observationsPauline Wimberger, Jacobus Pfisterer, Andreas du Bois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept StudyElisabeth Maritschnegg, Yuxuan Wang, Nina Pecha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2019
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trialBeyhan Ataseven, Johanna Frindte, Philipp Harter, et al.
Annals of Surgical Oncology|September 6, 2017
Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian CancerAnnett Kahl, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology|March 16, 2016
Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgeryFlorian Heitz, Philipp Harter, Piero F Alesina, et al.
Gynecologic Oncology|June 15, 2017
The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgeryChristoph Grimm, Philipp Harter, Pier F Alesina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2024
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay PerformanceMarcel Romey, Fiona Rodepeter, Akira Hattesohl, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMetCornelia Kolberg-Liedtke, Rachel Wuerstlein, Oleg Gluz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-MitteIrina Tsibulak, Rozita Hashemi, Julia Welz, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Cancers|July 26, 2020
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-ImagingHagen Kulbe, Oliver Klein, Zhiyang Wu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2025
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observationsPauline Wimberger, Jacobus Pfisterer, Andreas du Bois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept StudyElisabeth Maritschnegg, Yuxuan Wang, Nina Pecha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2019
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trialBeyhan Ataseven, Johanna Frindte, Philipp Harter, et al.
Annals of Surgical Oncology|September 6, 2017
Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian CancerAnnett Kahl, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology|March 16, 2016
Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgeryFlorian Heitz, Philipp Harter, Piero F Alesina, et al.
Gynecologic Oncology|June 15, 2017
The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgeryChristoph Grimm, Philipp Harter, Pier F Alesina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2024
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay PerformanceMarcel Romey, Fiona Rodepeter, Akira Hattesohl, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMetCornelia Kolberg-Liedtke, Rachel Wuerstlein, Oleg Gluz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-MitteIrina Tsibulak, Rozita Hashemi, Julia Welz, et al.
Pageof 18